@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix ns0: <https://lod.nal.usda.gov/naltv#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .

nalt:6556
  skos:prefLabel "antígenos"@es, "antigens"@en ;
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  skos:narrower nalt:10363 .

nalt:293039
  skos:prefLabel "antígenos específicos de melanoma"@es, "melanoma-specific antigens"@en ;
  a <https://lod.nal.usda.gov/naltv#Topic>, skos:Concept ;
  skos:broader nalt:10363 .

nalt:316946
  skos:prefLabel "vacunas contra el cáncer"@es, "cancer vaccines"@en ;
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  skos:related nalt:10363 .

nalt:702
  skos:prefLabel "neoplasmas"@es, "neoplasms"@en ;
  a <https://lod.nal.usda.gov/naltv#Topic>, skos:Concept ;
  skos:related nalt:10363 .

<https://lod.nal.usda.gov/naltv#Topic>
  rdfs:label "Topic"@en ;
  a owl:Class .

nalt:10363
  skos:related nalt:702, nalt:148923, nalt:316946 ;
  skos:prefLabel "neoplasm antigens"@en, "antígenos de neoplasias"@es ;
  a skos:Concept, <https://lod.nal.usda.gov/naltv#Topic> ;
  skos:hiddenLabel "neoplasm-antigens"@en, "tumor antigen"@en, "tumor antigens"@en ;
  skos:narrower nalt:293039 ;
  dc:modified "2020-09-10"^^xsd:date ;
  dc:created "2006-01-19"^^xsd:date ;
  skos:broader nalt:6556 ;
  ns0:marc001 "25085" ;
  skos:definition nalt:10363_def ;
  skos:inScheme <https://lod.nal.usda.gov/nalt> .

nalt:148923
  skos:prefLabel "antígeno prostático específico"@es, "prostate-specific antigen"@en ;
  a ns0:Chemical, skos:Concept ;
  skos:related nalt:10363 .

<https://lod.nal.usda.gov/nalt>
  rdfs:label "NALT Full"@en ;
  a skos:ConceptScheme .

nalt:10363_def
  rdf:value "Componentes de proteínas, glicoproteínas, o lipoproteínas que se encuentran en la superficie de las células tumorales que son usualmente identificados por anticuerpos monoclonales. Muchos de ellos son de origen embrionario o viral."@es, "Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin."@en ;
  dc:source "Medical Subject Headings" ;
  a ns0:Definition .